-
Featured Authors
-
Archives
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Category Archives: Corporate
Latest From Corporate
Research: Working Together Toward Cures
Modern biomedical innovation and the discovery of new cures and therapies for devastating diseases require robust collaboration and coordination among industry, research institutions and physicians. By bringing together the brightest minds in medical research, our nation’s research enterprise has successfully brought hundreds of new drugs, biologics, and vaccines to market in recent years and developed a wealth of clinical prescribing information. Ongoing research is advancing the fight against some of humanity’s worst scourges, such as Read More >
20th Anniversary of the BIO International Convention
Next year BIO will celebrate the 20th anniversary of the BIO International Convention April 22-25 in Chicago. From a small beginning, our convention has grown into the most influential biotech meeting in the world, attracting more than 16,500 attendees from 65 countries and providing a wide array of education, exhibits and networking opportunities — including more than 25,000 partnering meetings expected during the 4-day event. As we look forward to the upcoming Convention, I cannot Read More >
“When Genetic Engineering Came Of Age”
October 29 was the 30th anniversary of the approval by the Food and Drug Administration (FDA) of human insulin synthesized in genetically engineered bacteria. In an article for Forbes, Henry Miller, the founding director of the FDA’s Office of Biotechnology, marked the anniversary and commented on today’s regulatory environment: “Regulators have adopted a highly risk-averse and even adversarial mindset, few new drugs are approved without convening extramural advisory committees, and decisions are sometimes hijacked by Read More >
Sacrificing Energy Independence is Not the Solution
This past summer, as parts of the Midwest faced historic droughts and farmers and ranchers struggled with the impact of failing crops, a group of governors petitioned the Environmental Protection Agency (EPA) to suspend the federal Renewable Fuels Standard (RFS) as a way to provide relief. As temperatures cool and the drought stabilizes, it’s clear that government programs to provide emergency assistance for farmers and ranchers worked as intended. Yet, the call to suspend the Read More >
Southern California Biotech Magnet School will Prepare Next Gen Workforce
Despite increasing global competition, the United States remains the most innovative country on the planet. This competition, of course, is good because it means education and research are growing in the rest of the world. There is some debate as to whether or not this nation is facing a potential hi-tech labor shortage. Though, one thing is certain – teaching science, math, and technology to all kids is so important. This is not just because Read More >
